Anti-CD96 antibody (Samyang Biopharm/Talix Therapeutics)

N/A

Report date: 2025/04/29 16:55:46

Base Information

Drug NameAnti-CD96 antibody (Samyang Biopharm/Talix Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-T-cell surface protein tactile
TargetsT-cell surface protein tactile
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTalix Therapeutics NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSamyang Biopharm USA IncTalix Therapeutics NV
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A